Reduced likelihood of RCC in patients taking statins
This article has no abstract so we have provided the first paragraph of the full text.
Statins have been reported to have anticancer activity in various urological cancers, including bladder and prostate cancer. Khurana and colleagues have used data from the US South Central Veterans Integrated Service Network (a veterans' health care system that covers eight US states) to investigate the effect of statin use on the incidence of renal cell carcinoma (RCC). In total, 483,733 individuals who visited this health care system from October 1998 to June 2004 were included in the retrospective case–control study.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.